Development and application of a multicomponent film biocoating based on sodium carboxymethylcellulose to study the antibacterial activity of microflora in the oral fluid of patients with pemphigus vulgaris in vitro
- Authors: Koldarova E.V.1, Sidikov A.A.1, Mukhamedov B.I.2, Mukhamedov I.M.2, Sarymsakov A.A.3, Shukurov A.I.3, Zaslavsky D.V.4, Gorlanov I.A.4, Zaslavskaya E.D.4, Kozlova D.V.4
-
Affiliations:
- Fergana Medical Institute of Public Health
- Tashkent State Dental Institute
- Institute of polymer chemistry and physics, Academy of sciences of the Republic of Uzbekistan
- Saint-Petersburg State Pediatric Medical University
- Issue: Vol 28, No 1 (2025)
- Pages: 63-74
- Section: DERMATOLOGY
- Submitted: 30.10.2024
- Accepted: 01.02.2025
- Published: 06.05.2025
- URL: https://rjsvd.com/1560-9588/article/view/640799
- DOI: https://doi.org/10.17816/dv640799
- ID: 640799
Cite item
Abstract
BACKGROUND: A special place among dermatological diseases is occupied by dermatoses affecting the oral mucosa, in particular pemphigus vulgaris. Constant damage to the mucous membrane, combined with the presence of abundant microflora in the oral cavity, leads to rapid variability in the primary or pathognomonic manifestations of specific diseases, making them look similar. Erosion and ulcers in the oral cavity are very difficult to treat and are accompanied by severe pain. The role of the oral microflora in the development and progression of pemphigus vulgaris has not been fully studied, however, it is known that the microflora of patients differs significantly from that of healthy individuals. Today, much attention is paid to studying the composition, properties and role of the microflora of the oral mucosa in the manifestation and course of pemphigus vulgaris.
AIM: determination of the most effective combination of a three-component film biocoating based on sodium carboxymethylcellulose for patients with pemphigus vulgaris, by assessing and comparatively in vitro comparison of quantitative and qualitative characteristics of the oral microflora, as well as local oral protective factors (lysozyme titer, phagocytosis index neutrophils and the level of the secretory fraction of immunoglobulin class A)
MATERIALS AND METHODS: A cross-sectional single-center study was performed among patients with pemphigus vulgaris (n=12). Oral fluid was collected by washing (rinsing) 4.5 ml of physiological solution from the oral mucosa. Subsequently, in the laboratory, a series of serial dilutions were prepared, some of which were inoculated by quantitative sectoral sowing on media intended for the cultivation of aerobic and anaerobic microbes. Microbiological and immunological sensitivity to films with different concentrations of mometasone furoate (20–40–80 mg) and propolis (2.5–5–7.5–10%) was determined.
RESULTS: The most pronounced antibacterial activity was observed in the following 2-component forms (gel film and propolis at a concentration of 7.5%; gel film and mometasone furoate in an amount of 20 mg) and in 3-component gel films (gel film, propolis at a concentration of 5% and mometasone furoate 20 mg). According to the results of a comparative quantitative assessment of local factors protecting the oral cavity in patients with pemphigus vulgaris, their positive dynamics, characterized by the restoration of immunodeficiency, were most influenced by the three-component composition, including a gel film, propolis 5% and mometasone furoate 80 mg.
CONCLUSION: The three-component composition of the film biocoating based on carboxymethylcellulose significantly reduces the quantitative and improves the qualitative indicators of microorganisms in the oral cavity, thereby having a positive effect on the treatment process for patients with pemphigus vulgaris.
Keywords
Full Text

About the authors
Evelina V. Koldarova
Fergana Medical Institute of Public Health
Author for correspondence.
Email: koldarova7@gmail.com
ORCID iD: 0000-0001-9450-4004
SPIN-code: 5792-6185
Uzbekistan, Fergana
Akmal A. Sidikov
Fergana Medical Institute of Public Health
Email: medik-85@bk.ru
ORCID iD: 0000-0002-0909-7588
SPIN-code: 3812-8400
MD, Dr. Sci. (Medicine), Professor
Uzbekistan, FerganaBakhrambek I. Mukhamedov
Tashkent State Dental Institute
Email: mukhamedov69@gmail.com
ORCID iD: 0000-0002-7230-5183
SPIN-code: 8341-0974
MD, Cand. Sci. (Medicine), Assistant Professor
Uzbekistan, TashkentIlaman M. Mukhamedov
Tashkent State Dental Institute
Email: dr.ilaman@mail.ru
ORCID iD: 0009-0003-1001-5767
SPIN-code: 3013-4505
MD, Dr. Sci. (Medicine), Professor
Uzbekistan, TashkentAbdushukur A. Sarymsakov
Institute of polymer chemistry and physics, Academy of sciences of the Republic of Uzbekistan
Email: sarimsakov1948@gmail.com
ORCID iD: 0000-0002-1345-5288
Dr. Sci. (Engineering), Professor
Uzbekistan, TashkentAkobirkhon I. o’g’li Shukurov
Institute of polymer chemistry and physics, Academy of sciences of the Republic of Uzbekistan
Email: shukuroov@gmail.com
ORCID iD: 0000-0002-2889-0258
Uzbekistan, Tashkent
Denis V. Zaslavsky
Saint-Petersburg State Pediatric Medical University
Email: venerology@gmail.com
ORCID iD: 0000-0001-5936-6232
SPIN-code: 5832-9510
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Saint PetersburgIgor A. Gorlanov
Saint-Petersburg State Pediatric Medical University
Email: gorlanov53@mail.ru
ORCID iD: 0000-0001-9985-6965
SPIN-code: 1195-6225
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Saint PetersburgElizaveta D. Zaslavskaya
Saint-Petersburg State Pediatric Medical University
Email: zaslavliza@gmail.com
ORCID iD: 0000-0002-7434-3634
SPIN-code: 1218-8166
Russian Federation, Saint Petersburg
Darya V. Kozlova
Saint-Petersburg State Pediatric Medical University
Email: dashauchenaya@yandex.ru
ORCID iD: 0000-0002-6942-2880
SPIN-code: 3783-8565
Russian Federation, Saint Petersburg
References
- Olisova OY, Karamova AE, Znamenskaya LF, et al. Federal clinical recommendations for the management of patients with skin-limited vasculitis. Moscow; 2015. 21 р. (In Russ.) EDN: YQEIGJ
- Oskolsky GI, Zagorodnaya EB. Antigen KL-67 as a marker of proliferative processes in the epithelium of patients with red squamous lichen planus of the oral cavity mucosa. Far eastern journal of infectious pathology. 2011;(1):34–38. (In Russ.)
- Sreenivasan V. The malignant potential of oral lichen planus: Confusion galore. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(3):415. doi: 10.1016/j.oooo.2012.08.459
- Zaslavsky DV, Sydikov AA, Okhlopkov VA, Nasyrov RA. Skin lesions in diseases of internal organs. Moscow; 2020. 352 р. (In Russ.) EDN: QPYULG doi: 10.33029/9704-5379-7-РКО-2020-1-352
- Batkayev EA, Gallyamova YuA, Syuch NI, et al. Improvement of pemphigus vulgaris diagnosis. Russian journal of skin and venereal diseases. 2006;(5):49–51. EDN: IAMKBD
- Chebotarev VV, Sirak AG, Al-Asfari FM, Sirak SV. Common vesicular vesicles: Peculiarities of therapy in the oral cavity. Medical news of North Caucasus. 2014;9(3):215–217. (In Russ.) EDN: TCUVTX doi: 10.14300/mnnc.2014.09060
- Bulgakova AI, Hismatullina ZR, Gabidullina GF. Prevalence, etiology and clinical manifestations of blistering disease. Bashkortostan medical journal. 2016;11(6):86–90. EDN: XDZELD
- Sirak SV, Chebotarev VV, Sirak AG, Grigoryan AA. Development and application multicomponent adhesively ointment to treat erosive lesions of oral mucosa in patients with common bladderwort. Sovremennye problemy nauki i obrazovaniya. 2013;(2):15–22. EDN: RXUMHF
- Borovsky EV, Mashkilleyson NF, editors. Diseases of the mucous membrane of the oral cavity and lips. Moscow: MEDpress; 2001. Р. 177–194. (In Russ.)
- Kolenko YuG. Local application of nonsteroidal anti-inflammatory drug in the treatment of erosive and ulcerative lesions of the oral mucosa. East Eur Sci J. 2017;(2-2):57–61. EDN: XYDXNN
- Xiao J, Fiscella KA, Gill SR. Oral microbiome: Possible harbinger for children’s health. Int J Oral Sci. 2020;12(1):12. doi: 10.1038/s41368-020-0082-x
- Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: Dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745–759. doi: 10.1038/s41579-018-0089-x
Supplementary files
